End Canada’s criminal ban on contentious CRISPR gene-editing research, major science group urges – National Post
National Post |
End Canada’s criminal ban on contentious CRISPR gene-editing research, major science group urges
National Post CRISPR is a system that allows scientists to relatively easily and inexpensively edit or alter genes, including those passed on from generation to generation. It is lauded as a having the potential — still unproven — to save or transform lives by … |
National Post |
End Canada’s criminal ban on contentious CRISPR gene-editing research, major science group urges
National Post CRISPR is a system that allows scientists to relatively easily and inexpensively edit or alter genes, including those passed on from generation to generation. It is lauded as a having the potential — still unproven — to save or transform lives by … |
Genetic Engineering & Biotechnology News (press release) |
Flavor Genes in Yeast Undergo CRISPR Grafting to Produce Rosier Wines, More Honied Beers
Genetic Engineering & Biotechnology News (press release) “The causative genes were identified by reciprocal allele swapping into both parents using clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9,” the article’s authors explained. “The superior allele of the first major causative gene … |
Genetic Engineering & Biotechnology News (press release) |
Flavor Genes in Yeast Undergo CRISPR Grafting to Produce Rosier Wines, More Honied Beers
Genetic Engineering & Biotechnology News (press release) “The causative genes were identified by reciprocal allele swapping into both parents using clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9,” the article’s authors explained. “The superior allele of the first major causative gene … |
|
International Stem Cell Corporation to Present Six-Month Results of Neural Stem Cell Transplantation for Parkinson’s …
GlobeNewswire (press release) CARLSBAD, Calif., Nov. 08, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that its … |
|
International Stem Cell Corporation to Present Six-Month Results of Neural Stem Cell Transplantation for Parkinson’s …
GlobeNewswire (press release) CARLSBAD, Calif., Nov. 08, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that its … |